VIEW/PRINT T.I.P.S.™ PROGRAM KIT COMPONENTS
 T.I.P.S. Welcome Letter |
|
| Product Monograph |
|
| Procedures Booklet |
|
| Display Piece |
|
| Product Information (PI) |
TIKOSYN is indicated for the maintenance of normal sinus rhythm in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm.
TIKOSYN is indicated for the conversion of atrial fibrillation/atrial flutter to normal sinus rhythm.
_____________________________________________________________________________________________________
TIKOSYN is indicated for the conversion of atrial fibrillation/atrial flutter to normal sinus rhythm.
To minimize the risk of induced arrhythmia, patients initiated or re-initiated on TIKOSYN should be placed for a minimum of 3 days in a facility that can provide calculations of creatinine clearance, continuous electrocardiographic monitoring, and cardiac resuscitation (for detailed instructions regarding dose selection, see DOSAGE AND ADMINISTRATION). TIKOSYN is available only to hospitals and prescribers who have received appropriate TIKOSYN dosing and treatment initiation education (see DOSAGE AND ADMINISTRATION). For full Prescribing information, please click here.
____________________________________________________________________________________________________
Uninsured? Need help paying for medicines? Pfizer has programs that can help. Call 1-866-706-2400 or click here www.pfizerhelpfulanswers.com |
 |
_____________________________________________________________________________________________________
The product information in this site is intended for residents of the United States only.